100% Secure Payments
Tender Details
- Country: Czech Republic
- Summary: Delivers of Kymriah
- CZT Ref No: 60158777
- Deadline: 21 Dec 2021
- Competition: ICB
- Financier: Self Financed
- Purchaser Ownership: -
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: VZ0127493
- Purchaser's Detail :
- Description :
- Order name: Kymriah Center Media Supplies Home Brief Description: The subject of filling is a unique genomic drug used in biological treatment called T-lymphocyte therapy chimeric antigenic receptor (Car). T-lymphocytes are immune cells taken from the blood of the patient and again in the right to the body through intravenous infusion. Kymriah contains the active substance TISAGENCLEUCEL and is only available as a branded medicine. There are currently no so-called. Biosimilars, ie., There is currently no medicine that would be considered as effective and safe. There are only alternative treatments that may, but may not be appropriate for a given patient who is determined by this medicament.
System number: P21V00206783
Internal number: Jůrba-02/21
Offers deadline: 21. 12. 2021 13:30:00
Contact Person
Jana Zakilová
+420 597 373 452
, Jana.chytilova@fno.cz - Documents :
Purchaser : UNIVERSITY HOSPITAL OSTRAVA
17 November 1790/5, 708 52 Ostrava - Poruba, Czech Republic Home Phone: +420 597 371 1111
Email :fno@fno.cz
URL :www.fno.cz
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGIN
